A carregar...
Endocrine side effects of broad-acting kinase inhibitors
Targeted therapy in oncology consists of drugs that specifically interfere with abnormal signaling pathways that are dysregulated in cancer cells. Tyrosine kinase inhibitors (TKIs) take advantage of unique oncogenes that are activated in certain types of cancer, and also target common mechanisms of...
Na minha lista:
| Main Authors: | , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2010
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3039175/ https://ncbi.nlm.nih.gov/pubmed/20603395 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1677/ERC-10-0082 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|